The clonal composition of EBV-infected cells was examined in three cases of EBVassociated hemophagocytic syndrome by analysis of the heterogeneity of terminal repetitive sequences in the EBV genome, indicating monoclonal expansion of EBV-infected cells in all cases. Involvement of T lymphoid cells was determined by in situ hybridization using 35S-labeled RNA probes specific for the small EBV-encoded nuclear RNAs, EBER1 and EBER2, in combination with immunostaining for the TCR-beta chain, CD45RO, CD20, CD30 and CD68 antigens in these three cases. The majority of lymphoid cells showing EBER transcripts were stained by antibodies against CD45RO and T cell receptor-beta. In contrast, EBER-specific signals were not detectable on B cells or hemophagocytic cells. These data support the concept that EBV-associated T cell proliferation is a primary feature of EBV-AHS.
Introduction
Virus-associated hemophagocytic syndrome (VAHS)' is a histiocytic proliferative disorder associated with viral infection ( 1, 2) . Clinically, patients with VAHS have high fever, skin rash, hepatosplenomegaly, pancytopenia, and coagulopathy, and morphologic examination of lymph node and bone marrow demonstrates prominent phagocytosis of erythrocytes and nucleated blood cells. In contrast to malignancies considered to 1 . Abbreviations used in this paper: BM, bone marrow; EA, early antigen; EBNA, Epstein-Barr nuclear antigen; EBV-AHS, Epstein-Barr virus-associated hemophagocytic syndrome; MNC, mononuclear cell; PB, peripheral blood; TCR, T cell receptor; VAHS, virus-associated hemophagocytic syndrome; VCA, viral capsid antigen.
be ofhistiocytic origin, such as malignant histiocytosis (3) and histiocytic medullary reticulosis (4) , the accumulation ofphagocytosing histiocytes in VAHS is thought to be a reactive condition, although the pathogenesis of this process is poorly understood.
Among various infectious agents, herpesviruses, particularly EBV, have been implicated in the pathogenesis of VAHS (1, 2) . EBV is a ubiquitous pathogen in human populations throughout the world. Infection is usually not associated with clinical disease except for infectious mononucleosis in developed countries. EBV-infected B cells are immortalized and persist in the host for life. The virus is also associated with various types of malignancies such as Burkitt lymphoma, nasopharyngeal carcinoma (5), T cell lymphoma (6, 7) , and polyclonal B cell lymphoproliferation (8) in immunosuppressed individuals. We report here that in cases ofEBV-associated hemophagocytic syndrome (EBV-AHS) there is a clonal proliferation of EBV-infected T cells but not of EBV-infected B cells or histiocytes. We propose that these EBV-infected T cells may be responsible for causing the clinical features of EBV-AHS.
Methods
Case reports. The clinical and laboratory data ofthe three cases studied are given in Table I (9) . The association with EBV was suggested by the elevation of anti-EBV antibodies in cases A and C (Table I B) .
Serological studiesfor EB V. Antibody titers against EBV-viral capsid antigen (VCA), early antigen (EA), and Epstein-Barr nuclear antigen (EBNA) were determined by established methods (10 Immunohistology and in situ hybridization. The production and specificity profiles of the monoclonal antibodies specific for LMP1 (clones CS1, -2, -3, and -4) are described elsewhere (16) . To define the cellular lineage of EBV-infected cells, double labeling was performed by in situ hybridization to the EBV-encoded small RNAs EBERI and EBER2 (17) , in combination with immunostaining for TCR-fl, CD45RO (18) (T cell antigens), CD20 (B cell antigen), CD68 (macrophage/histiocytic antigen), and CD30 (activation marker) (19) (20) (21) . Monoclonal antibodies against CD20 (L26), CD30 (Ber-H2), and CD68 (KP-1) were obtained from Dakopatts (Glostrup, Denmark). The anti-TCR-,B chain antibody, ,BF1, was from T Cell Sciences, Inc. (Cambridge, MA), and the CD45RO-specific antibody A6 was a kind gift of Dr. G. G. Aversa (Stanford University, Stanford, CA). 4-gm sections of formol-fixed, paraffin-embedded tissue blocks were stained by the immunoalkaline method (22) . Affinity-purified rabbit antimouse Ig antibody and alkaline phosphatase-anti-alkaline phosphatase complex (diluted 1:20) were obtained from Dakopatts. After visualization of immobilized antibodies, slides were immediately subjected to the in situ hybridization procedure. In situ hybridization protocol was the same as described previously (20, 21) . Briefly, EBERI-and EBER2-specific fragments were derived from the plasmids pJJJ1 and of EBERl-and EBER2-specific RNA probes was applied to increase the sensitivity.
Results
Case A had elevated anti-EBNA, VCA-IgG, and EA titers, which suggests that the disease was not associated with primary EBV infection. On the other hand, case C showed absence of anti-EBNA antibody with the presence of VCA-IgM, indicating a primary EBV infection. By Southern hybridization analysis on the BamHI-digested DNA extracted from BM MNCs, discrete single bands > 7 kb were detected using the 1.9-kb XhoI probe (Fig. 1 ). This suggests that each sample contains a single episomal form ofEBV and agrees with the interpretation that EBV-infected cells proliferate monoclonally. An additional 4.5-kb single band was found in case B.
The histologic features, in situ hybridization, and immunohistology patterns are shown in Fig. 2 cytosing histiocytes in EBV-AHS is poorly understood. In this study, in situ hybridization and immunostaining results demonstrated that CD45RO-positive T cells are infected with EBV. Considering the observation that EBV-infected cells proliferate monoclonally in EBV-AHS, a reasonable conclusion is that these clonal cells are EBV-infected CD45RO-positive T cells. Although the EBV-infected T cells may be monoclonal with respect to the structure ofthe viral genome, no clonal rearrangement ofTCR-( or-y genes was detected by Southern hybridization in these cases. This may be due to the involvement ofonly a small number ofEBV-infected T cells in the samples used for DNA extraction below the threshold ofdetection with the TCR genes. This is plausible since the viral DNA may be amplified up to 100-fold in infected cells, whereas the antigen receptor genes are only present as a single copy. An alternative explanation is that EBV infection of T cells may have occurred before rearrangements of TCR genes, so that EBV-harboring T cells may possess an oligoclonal composition in some cases ofEBV-AHS. It remains to be determined whether these clonally expanded EBV-infected T cells represent proliferations of nontransformed T cells or whether, at least in some cases, they are manifestations of a peripheral T cell lymphoma of low malignancy. However, the cytological characteristics of the EBERpositive T (25) , although the accumulation of hemophagocytic cells is similarly associated with underlying T cell disease in both our cases and theirs. Many cases of EBV-AHS exhibit a clinically benign course, while others show a more aggressive manifestation of the disorder with repeated occurrences ofthe EBV-harboring cell clone (9) . This favors the view that the EBV-infected T cells in EBV-AHS represent a range from preneoplastic to overtly malignant proliferations.
In On the basis of our data, proliferations of EBV-infected T cells must be regarded as a primary feature of EBV-AHS. Our findings suggests that EBV-infected T cells might induce the accumulation and the phagocytosing behavior of histiocytes and macrophages. Such phagocytic histiocytes have not been recognized in the few examples ofEBV-infected T cell diseases, including most T cell lymphomas (6, 7), lethal midline granuloma (35) , and Kawasaki-like disease (36) . Thus, EBV-AHS represents a subset of EBV-infected T cell diseases characterized by the accumulation and proliferation ofhemophagocytic macrophages, as has been recognized in a particular type of T cell lymphoma (24) . The results of our study also have important implications for the treatment of this disorder. The treatment strategy for EBV-AHS should include methods to eradicate EBV-infected T cells as well as hemophagocytic histiocytes.
